Aristea Therapeutics
San Diego, US · Founded 2018 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
JM
James MackayExecutive
Board
LT
Loretta TseBoard director
KH
Kenneth HarrisonBoard director
TA
CK
Ciara KennedyBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$63.1M disclosed across 1 round · 2020
▶$63.1MraisedAug 2021 · 15 investors · BiotechnologyRule 506(b)
▶$63.1MraisedAug 2021 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Loretta TseDirector
- James MackayExecutive Officer, Director
- Kenneth HarrisonDirector
- Tiba AynechiDirector
- Ciara KennedyDirector
- Offering amount
- $63.1M
- Amount sold
- $63.1M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Aristea Therapeutics's investors?
- Aristea Therapeutics's investors include Norwest Venture Partners.
- How much funding has Aristea Therapeutics raised?
- Aristea Therapeutics has disclosed $63.1M raised across 1 round.
- Where is Aristea Therapeutics headquartered?
- Aristea Therapeutics is headquartered in San Diego, US.